Key facts
- Notable investors include Archer Daniels Midland, Asia Sustainable Foods, Economic Development Innovations Singapore.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ScaleUp Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for ScaleUp Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ScaleUp Bio
Provider of technology development and precision fermentation for microbial-based alternative protein in Singapore and the wider Asia-Pacific region. The joint venture intends to develop microbial-based proteins to create alternatives to meat and dairy proteins and other in-demand food and beverage solutions for companies serving the growing consumer demand for a wide variety of bio-based products, thereby offering a one-stop-shop for both startups and mature businesses looking for support in food-grade fermentation, downstream processing, lab services and consulting.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Singapore, Singapore
- Founded
- 2021
- Website
- scaleupbio.com/
- Ownership
- Privately Held (backing)
ScaleUp Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ScaleUp Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ScaleUp Bio in its N-PORT filings yet. We sweep new filings monthly.